National Lung Cancer Registry in Men and Women based on Diagnosis in Algeria

Trial Identifier: D133FR00108
Sponsor: AstraZeneca
NCTID:: NCT02725892
Start Date: July 2016
Primary Completion Date: February 2021
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Algeria Algiers, Algeria, 16000
Algeria constantine, Algeria, 25000
Algeria Oran, Algeria, 31000